Rhumbline Advisers Atri Cure, Inc. Transaction History

Rhumbline Advisers

  • $104 Billion
  • Q1 2025

A detailed history of Rhumbline Advisers transactions in Atri Cure, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 70,919 shares of ATRC stock, worth $2.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70,919
Previous 70,919 -0.0%
Holding current value
$2.14 Million
Previous $2.26 Million 1.33%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 08, 2025
SELL
$30.4 - $42.4 $240,038 - $334,790
-7,896 Reduced 10.02%
70,919 $2.26 Million
Q4 2024

May 29, 2025
BUY
$27.02 - $38.2 $213,349 - $301,627
7,896 Added 11.13%
78,815 $2.41 Million
Q4 2024

Jan 30, 2025
BUY
$27.02 - $38.2 $217,511 - $307,510
8,050 Added 11.38%
78,815 $2.41 Million
Q3 2024

Nov 12, 2024
SELL
$20.34 - $29.5 $44,158 - $64,044
-2,171 Reduced 2.98%
70,765 $1.98 Million
Q2 2024

Aug 01, 2024
BUY
$19.86 - $29.09 $51,179 - $74,964
2,577 Added 3.66%
72,936 $1.66 Million
Q1 2024

May 09, 2024
BUY
$28.21 - $37.78 $45,023 - $60,296
1,596 Added 2.32%
70,359 $2.14 Million
Q4 2023

Feb 08, 2024
SELL
$32.99 - $43.25 $13,789 - $18,078
-418 Reduced 0.6%
68,763 $2.45 Million
Q3 2023

Nov 09, 2023
SELL
$41.12 - $57.73 $119,741 - $168,109
-2,912 Reduced 4.04%
69,181 $3.03 Million
Q2 2023

Aug 08, 2023
BUY
$40.44 - $49.6 $189,380 - $232,276
4,683 Added 6.95%
72,093 $3.56 Million
Q1 2023

May 11, 2023
BUY
$35.87 - $47.22 $50,612 - $66,627
1,411 Added 2.14%
67,410 $2.79 Million
Q4 2022

Feb 14, 2023
BUY
$33.48 - $47.45 $42,686 - $60,498
1,275 Added 1.97%
65,999 $2.93 Million
Q3 2022

Nov 10, 2022
BUY
$38.25 - $52.62 $182,414 - $250,944
4,769 Added 7.95%
64,724 $2.53 Million
Q2 2022

Aug 11, 2022
BUY
$35.1 - $66.01 $299,367 - $562,999
8,529 Added 16.58%
59,955 $2.45 Million
Q1 2022

May 12, 2022
SELL
$57.43 - $71.39 $4,422 - $5,497
-77 Reduced 0.15%
51,426 $3.38 Million
Q4 2021

Feb 10, 2022
SELL
$63.4 - $87.14 $37,406 - $51,412
-590 Reduced 1.13%
51,503 $3.58 Million
Q3 2021

Nov 12, 2021
BUY
$69.28 - $84.46 $128,583 - $156,757
1,856 Added 3.69%
52,093 $3.62 Million
Q2 2021

Aug 05, 2021
SELL
$64.13 - $80.18 $150,192 - $187,781
-2,342 Reduced 4.45%
50,237 $3.99 Million
Q1 2021

May 06, 2021
SELL
$53.79 - $66.98 $376,906 - $469,328
-7,007 Reduced 11.76%
52,579 $3.45 Million
Q4 2020

Feb 10, 2021
BUY
$34.56 - $57.55 $99,463 - $165,628
2,878 Added 5.08%
59,586 $3.32 Million
Q3 2020

Nov 12, 2020
SELL
$38.36 - $46.91 $384,098 - $469,709
-10,013 Reduced 15.01%
56,708 $2.26 Million
Q2 2020

Aug 13, 2020
BUY
$31.78 - $51.19 $263,774 - $424,877
8,300 Added 14.21%
66,721 $3 Million
Q1 2020

May 06, 2020
BUY
$24.49 - $43.84 $145,176 - $259,883
5,928 Added 11.29%
58,421 $1.96 Million
Q4 2019

Feb 05, 2020
BUY
$24.06 - $32.51 $29,281 - $39,564
1,217 Added 2.37%
52,493 $1.71 Million
Q3 2019

Oct 23, 2019
BUY
$23.81 - $32.52 $7,381 - $10,081
310 Added 0.61%
51,276 $1.28 Million
Q2 2019

Aug 14, 2019
BUY
$26.85 - $30.74 $59,821 - $68,488
2,228 Added 4.57%
50,966 $1.52 Million
Q1 2019

May 01, 2019
BUY
$26.38 - $33.34 $42,049 - $53,143
1,594 Added 3.38%
48,738 $1.31 Million
Q4 2018

Jan 31, 2019
BUY
$26.66 - $34.85 $445,888 - $582,866
16,725 Added 54.98%
47,144 $1.44 Million
Q3 2018

Nov 07, 2018
SELL
$27.62 - $35.58 $56,234 - $72,440
-2,036 Reduced 6.27%
30,419 $1.07 Million
Q2 2018

Aug 06, 2018
BUY
$19.65 - $30.28 $55,157 - $84,995
2,807 Added 9.47%
32,455 $878,000
Q1 2018

May 02, 2018
SELL
$15.05 - $21.03 $15,050 - $21,030
-1,000 Reduced 3.26%
29,648 $608,000
Q4 2017

Feb 09, 2018
SELL
$17.69 - $23.44 $103,804 - $137,545
-5,868 Reduced 16.07%
30,648 $559,000
Q3 2017

Nov 06, 2017
BUY
$20.0 - $24.23 $730,320 - $884,782
36,516
36,516 $817,000

Others Institutions Holding ATRC

# of Institutions
236
Shares Held
51.9M
Call Options Held
32.6K
Put Options Held
4.5K
View Full List

About AtriCure, Inc.

ATRC Quotes by TradingView
  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.4B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email